Focus Financial Network Inc. Lowers Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Focus Financial Network Inc. reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,988 shares of the financial services provider’s stock after selling 159 shares during the period. Focus Financial Network Inc.’s holdings in iShares Biotechnology ETF were worth $1,163,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the company. Highline Wealth Partners LLC purchased a new position in iShares Biotechnology ETF in the third quarter worth $30,000. Bbjs Financial Advisors LLC purchased a new stake in iShares Biotechnology ETF in the second quarter worth approximately $31,000. Voisard Asset Management Group Inc. bought a new position in iShares Biotechnology ETF during the third quarter valued at approximately $59,000. Chris Bulman Inc purchased a new position in shares of iShares Biotechnology ETF during the second quarter worth approximately $64,000. Finally, Eastern Bank bought a new stake in shares of iShares Biotechnology ETF in the 3rd quarter worth approximately $65,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 1.8 %

Shares of iShares Biotechnology ETF stock opened at $142.78 on Friday. The company has a fifty day moving average of $145.02 and a 200-day moving average of $140.37. iShares Biotechnology ETF has a 52-week low of $113.56 and a 52-week high of $150.57.

iShares Biotechnology ETF Announces Dividend

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.